Transmitters that are primarily or secondarily involved in the pathogenesis
of schizophrenia have been extensively studied for many years. This review
will focus on the transmitter systems that are known to be directly or ind
irectly involved in the mode of action of the novel atypical antipsychotics
and clozapine, i.e, the dopaminergic, serotonergic and glutamatergic syste
ms. The consequences of transmitter dysfunction for perception and for the
ability of the individual to adapt to a constantly changing environment are
discussed, and a hypothesis that can explain how a primary cortical defect
will progressively involve secondary transmitter dysfunction and spontaneo
us dopaminergic sensitization is proposed. According to the suggested hypot
hesis for the pathogenesis of development of schizophrenic symptoms, pharma
cological treatment strategies should focus on flexible as opposed to rigid
modulation of sensorimotor gating. The hypothetical effects of serotonergi
c and dopaminergic interactions on sensorimotor gating are illustrated, and
the implications of the broader receptor profile of atypical antipsychotic
s for the reduced capacity to induce extrapyramidal side-effects and the su
pposedly superior effect on cognitive dysfunction and negative symptoms are
discussed.